MS
Michael B Sheffery
Director

Michael B Sheffery insider trades: Supernus Pharmaceuticals (SUPN) stock purchases

Director, Supernus Pharmaceuticals Last trade May 4, 2012 10 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2007
3
Companies
last trade 2012

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Michael reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 4, 2012SUPN↑ Buy$3.7M
May 4, 2012SUPN↑ Buy$1.4M
May 4, 2012SUPN↑ Buy$455K
Mar 17, 2009ATHX↑ Buy$126K
May 22, 2008ATHX↑ Buy$643K
May 21, 2008ATHX↑ Buy$312K
May 13, 2008ATHX↑ Buy$120K
Jun 8, 2007BVIC↑ Buy$15.0M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other SUPN insiders

Open-market trades in the last 12 months

About Michael B Sheffery's insider trades

Michael B Sheffery is a director at Supernus Pharmaceuticals (SUPN). Since Jun 8, 2007, Michael has reported 8 open-market purchases worth $21.7M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (7 filings), other transactions (5 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SUPN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.